Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Classical hematology 2Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Multiple Myeloma 3Immunologic Deficiency Syndromes 2Thalassemia 1Neoplasms 1Myelodysplastic Syndromes 1Muscle Neoplasms 1Metabolic Diseases 1Melanoma 1Lymphoma 1Hemoglobinopathies 1Hematologic Neoplasms 1Fanconi Anemia 1Chronic Pain 1Breast Neoplasms 1Anemia, Sickle Cell 1Anemia, Aplastic 1

Interventions

fludarabine 3Melphalan 2fludarabine phosphate 1Thiotepa 1Mesna 1Influenza Vaccines 1Honey 1Cyclophosphamide 1Clofarabine 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Immunologic Deficiency Syndromes × Melphalan × Clear all
NCT03016806 2025-10-10

Umbilical Cord Blood Transplantation From Unrelated Donors

University of Rochester

Recruiting
30 enrolled
Classical hematologyLymphoidMyeloidPlasma cell

Anemia, Aplastic, Immunologic Deficiency Syndromes, Lymphoma, Metabolic Diseases, Multiple Myeloma, Myelodysplastic Syndromes

NCT03609827 2021-10-04

Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients

University of California, San Francisco

Completed
25 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Immunologic Deficiency Syndromes, Thalassemia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡